Event Overview

microRNA (miRNA)-mediated transformation of cancer cell transcriptomes underlies pathogenic mechanisms and potential therapeutic approaches. Using miRNAs for cancer therapeutics, however, has encountered roadblocks in terms of delivery efficacy, toxicity, and immunogenicity. In this webinar brought to you by The Scientist, Andrea Kasinski and Masako Harada will explore new ways to overcome these challenges and discuss how they develop more effective miRNA delivery strategies.

Topics to be covered

  • Ligand-based miRNA delivery
  • Using extracellular vesicles for targeted microRNA delivery

  • Tuesday, February 8, 2022
    2:30 - 4:00 PM Eastern Time 

    Meet the speakers

    Andrea Kacinski, PhD
    Associate Professor
    Biological Sciences
    Purdue University

    Masako Harada, PhD
    Assistant Professor
    Biomedical Engineering
    Michigan State University

    Sponsored by



    TS_Webinar_Bio-Rad_LabTools_Droplet Digital PCR: When qPCR Doesn’t Make the Cut November 4, 2021_IO#403220

    You must have Javascript and Cookies enabled to access this webcast.

    Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.